Lifecore Biomedical, Inc.
LFCR · NASDAQ
5/25/2025 | 5/26/2024 | 5/28/2023 | 5/29/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 0.5% | 24.2% | -7.2% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 31.3% | 32.6% | 27.1% | 35.1% |
| EBITDA | -$0 | $0 | -$0 | $0 |
| % Margin | -6.8% | 27.8% | -32.1% | 11.5% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -30% | 9.4% | -96.4% | -104.9% |
| EPS Diluted | -1.27 | 0.33 | -3.32 | -3.97 |
| % Growth | -484.8% | 109.9% | 16.4% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |